rotenone has been researched along with Cancer of Prostate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bridges, HR; Hirst, J; Kidd, SL; Mateu, N; Osberger, TJ; Russell, DA; Serreli, R; Sore, HF; Spring, DR | 1 |
| Ambrico, A; Chandel, NS; Di Francesco, ME; El-Amine, N; Herzka, T; Lee, MF; Marszalek, JR; Mathew, G; Naguib, A; Pappin, DJ; Reczek, CR; Salas, IC; Trotman, LC; Watrud, K; Zheng, W | 1 |
| Chen, HB; Chen, S; Hu, XH; Jiang, KH; Lan, Y; Song, XF; Wang, YL; Yuan, HG; Yuan, W; Zhao, CX; Zhu, SL | 1 |
| Menon, M; Thamilselvan, S; Thamilselvan, V | 1 |
| Epner, DE; Kouvroukoglou, S; Lakkis, CL; Wallace, JD; Zygourakis, K | 1 |
| Hagopian, K; Oberley, TD; Ripple, MO; Schatten, H; Weindruch, R | 1 |
| Balnbury, L; Borges-Argáez, R; Flowers, A; Giménez-Turba, A; Peña-Rodríguez, LM; Ruiz, G; Waterman, PG | 1 |
7 other study(ies) available for rotenone and Cancer of Prostate
| Article | Year |
|---|---|
Hydroxylated Rotenoids Selectively Inhibit the Proliferation of Prostate Cancer Cells.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Cattle; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Electron Transport Complex I; Humans; Male; Mitochondrial Membranes; Molecular Structure; Prostatic Neoplasms; Rotenone; Uncoupling Agents | 2020 |
Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cells, Cultured; Electron Transport Complex I; Enzyme Inhibitors; Fibroblasts; Glucose; Male; Mice; Prostatic Neoplasms; PTEN Phosphohydrolase; Rotenone; Tumor Suppressor Protein p53 | 2018 |
[Inhibitory effect of Akt inhibitor deguelin on the growth of PC-3 prostate cancer cells].
Topics: Cell Line, Tumor; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Rotenone | 2013 |
Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
Topics: Antineoplastic Agents; beta Catenin; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Rotenone; Signal Transduction | 2011 |
Bioenergetics of rat prostate cancer cell migration.
Topics: Adenocarcinoma; Adenosine Triphosphate; Animals; Antimycin A; Cell Movement; Culture Media; Electron Transport; Glycolysis; Lactates; Male; Oxygen Consumption; Prostatic Neoplasms; Rats; Rotenone; Time Factors; Tumor Cells, Cultured | 1998 |
Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications.
Topics: Antimycin A; Coloring Agents; DNA; Electron Transport; Fluoresceins; Fluorescent Dyes; Humans; Hydroxyl Radical; Male; Metribolone; Mitochondria; Oxidative Stress; Peroxides; Prostatic Neoplasms; Rotenone; Testosterone Congeners; Tetrazolium Salts; Thiazoles; Time Factors; Tocopherols; Tumor Cells, Cultured; Uncoupling Agents; Vitamin E | 1999 |
Cytotoxic and antiprotozoal activity of flavonoids from Lonchocarpus spp.
Topics: Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Cell Cycle; Cell Line, Tumor; Derris; Flavones; Humans; Leukemia; Male; Molecular Structure; Phytotherapy; Prostatic Neoplasms | 2007 |